ORCL
63
-4
EXR
57
2
ED
45
3
KLAC
38
-6
CVX
43
-3
DOV
65
-4
GOOG
57
-6
TROW
47
-6
KEY
43
-3
LEN
50
-2
MRO
50
4
FOX
51
-6
STT
64
2
ADM
28
3
CVS
41
-4
IFF
47
-4
NOV
52
-5
AMT
37
3
GME
66
-5
TGNA
50
-6
ORCL
63
-4
EXR
57
2
ED
45
3
KLAC
38
-6
CVX
43
-3
DOV
65
-4
GOOG
57
-6
TROW
47
-6
KEY
43
-3
LEN
50
-2
MRO
50
4
FOX
51
-6
STT
64
2
ADM
28
3
CVS
41
-4
IFF
47
-4
NOV
52
-5
AMT
37
3
GME
66
-5
TGNA
50
-6
Financhill
Back

Invesco DB Precious Metals Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
18

DBP
Invesco DB Precious Metals

Last Price:
62.10
Seasonality Move:
3.81%
Sell
20

ALNY
Alnylam Pharmaceuticals

Last Price:
235.53
Seasonality Move:
10.85%
Sell
18
Invesco DB Precious Metals (DBP) is a Sell

Is Invesco DB Precious Metals a Buy, Sell or Hold?

  • The current Invesco DB Precious Metals [DBP] share price is $62.10. The Score for DBP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • DBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $235.56. The Score for ALNY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DBP Stock Price Chart

What is Invesco DB Precious Metals's stock price today?

  • The Invesco DB Precious Metals share price today is $62.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBP is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $235.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

DBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 34.08 Sell
Chaikin Money Flow: -16730 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.68 - 67.12) Sell
Bollinger Bands (100): (58.82 - 64.8) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.97 Sell
Relative Strength Index (14 RSI): 27.06 Sell
Chaikin Money Flow: -1631558 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (264.56 - 293.18) Sell
Bollinger Bands (100): (249.23 - 281.59) Sell

DBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.47 Sell
20-day SMA: 65.5 Sell
50-day SMA: 64.35 Sell
200-day SMA: 58.28 Buy
8-day EMA: 63.39 Sell
20-day EMA: 64.47 Sell
50-day EMA: 63.97 Sell
200-day EMA: 59.19 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 266.17 Sell
20-day SMA: 276.01 Sell
50-day SMA: 273.94 Sell
200-day SMA: 209.89 Buy
8-day EMA: 261.6 Sell
20-day EMA: 270.55 Sell
50-day EMA: 270.52 Sell
200-day EMA: 230.49 Buy

Invesco DB Precious Metals Earnings Growth & DBP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Invesco DB Precious Metals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):